[Treatment of inflammatory lesions of the mouth and pharynx using Imposit].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002594:Cetylpyridinium / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004952:Esters / Q000627:therapeutic use; D006096:Gramicidin / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D010612:Pharyngitis / Q000188:drug therapy*; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D014069:Tonsillitis / Q000188:drug therapy
D004338:Drug Combinations; D004952:Esters; D011726:Pyridinium Compounds; D006096:Gramicidin; D002594:Cetylpyridinium
Zur Behandlung entzündlicher Affektionen des Mundund Rachenraums mit Imposit.